Skip to main content

Peer Review reports

From: High-content analysis identified synergistic drug interactions between INK128, an mTOR inhibitor, and HDAC inhibitors in a non-small cell lung cancer cell line

Original Submission
7 Sep 2023 Submitted Original manuscript
20 Oct 2023 Reviewed Reviewer Report
21 Nov 2023 Reviewed Reviewer Report
4 Jan 2024 Author responded Author comments - Jungseog Kang
Resubmission - Version 2
4 Jan 2024 Submitted Manuscript version 2
17 Jan 2024 Reviewed Reviewer Report
23 Jan 2024 Reviewed Reviewer Report
10 Feb 2024 Author responded Author comments - Jungseog Kang
Resubmission - Version 3
10 Feb 2024 Submitted Manuscript version 3
11 Feb 2024 Author responded Author comments - Jungseog Kang
Resubmission - Version 4
11 Feb 2024 Submitted Manuscript version 4
25 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
26 Feb 2024 Editorially accepted
12 Mar 2024 Article published 10.1186/s12885-024-12057-4

You can find further information about peer review here.

Back to article page